Abbott Laboratories Sees Q4 Adj EPS $1.62-$1.67 vs $1.64 Est
Abbott Laboratories (NYSE:ABT) is looking for Q4 Adj EPS of $1.62-$1.67 vs $1.64 analyst estimate..
Share
Why It Matters
Abbott said its fourth quarter earnings will be about the same as experts predicted. When a big company meets what people expect, it shows the business is running pretty steady.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.